Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 2/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | PGK1 | P00558 | 1/20 | 0.33 |
| ▸ | PGK2 | P07205 | 1/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29391870 | 1.00 | TYR (0.48) | TYRNPSR1PGK1PGK2TRPV1 | |
| SCHEMBL27946078 | 0.86 | TYR (0.53) | TYRNPSR1TRPV1MAPTALDH1A1 | |
| SCHEMBL113499 | 0.78 | TYR (0.53) | TYRALDH1A1 | |
| SCHEMBL31498230 | 0.78 | TYR (0.53) | TYRALDH1A1 | |
| SCHEMBL27928021 | 0.76 | TYR (0.47) | TYR | |
| SCHEMBL29737291 | 0.75 | NPSR1 (0.50) | NPSR1PGK1PGK2MAPTALDH1A1 | |
| SCHEMBL3199545 | 0.75 | NPSR1 (0.50) | NPSR1PGK1PGK2MAPTALDH1A1 | |
| SCHEMBL15319377 | 0.75 | TYR (0.54) | TYR | |
| SCHEMBL1716142 | 0.72 | TAAR1 (0.52) | TYRALDH1A1 | |
| SCHEMBL8129415 | 0.72 | TYR (0.51) | TYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1651037-A1 | SECONDARY ALCOHOLS USED AS ANTIMICROBIAL AGENTS | Symrise GmbH & Co. KG (DE) | 2006-05-03 | — | — | EP | claimed |
| WO-2005004601-A1 | SECONDARY ALCOHOLS USED AS ANTIMICROBIAL AGENTS | SYMRISE GMBH & CO. KG (DE) | 2005-01-20 | — | — | WO | claimed |
| US-12441953-B2 | Isomer mixtures of unsaturated macrocyclic musk compounds | SYMRISE AG (DE) | 2025-10-14 | — | — | US | disclosed |
| EP-4624559-A2 | ISOMER MIXTURES OF UNSATURATED MACROCYCLIC MUSK COMPOUNDS | Symrise AG (DE) | 2025-10-01 | — | — | EP | disclosed |
| EP-3898910-B1 | ALICYCLIC MUSK FRAGRANCE COMPOUNDS | SYMRISE AG (DE) | 2025-09-03 | — | — | EP | disclosed |
| EP-3880777-B1 | PERFUMING INGREDIENTS WITH LILY OF THE VALLEY NOTE | SYMRISE AG (DE) | 2025-06-25 | — | — | EP | disclosed |
| EP-4006130-B1 | ISOMER MIXTURES OF UNSATURATED MACROCYCLIC MUSK COMPOUNDS | SYMRISE AG (DE) | 2025-04-09 | — | — | EP | disclosed |
| EP-4519244-A1 | NOVEL FRAGRANCE COMPOUNDS | Symrise AG (DE) | 2025-03-12 | — | — | EP | disclosed |
| US-12110472-B2 | Perfuming ingredients with lily of the valley note | SYMRISE AG (DE) | 2024-10-08 | — | — | US | disclosed |
| US-12031106-B2 | Use of 1-ethyl-4,4-dimethyl-cyclohexane derivatives as fragrances | SYMRISE AG (DE) | 2024-07-09 | — | — | US | disclosed |
| EP-2966158-B2 | Isomers mixtures of unsaturated macrocyclic musk compounds | SYMRISE AG (DE) | 2024-03-13 | — | — | EP | disclosed |
| EP-2307357-A1 | L-MENTHYL-N-(2-HYDROXYPHENYL)CARBAMATE | Symrise AG (DE) | 2011-04-13 | — | — | EP | disclosed |
| EP-2133102-A1 | Odor reducers | Symrise GmbH & Co. KG (DE) | 2009-12-16 | — | — | EP | disclosed |
| WO-2009144179-A1 | L-MENTHYL-N-(2-HYDROXYPHENYL)CARBAMATE | SYMRISE GMBH & CO. KG (DE) | 2009-12-03 | — | — | WO | disclosed |
| US-20090238787-A1 | ODOUR-REDUCING SUBSTANCES | SYMRISE GMBH & CO. KG (DE) | 2009-09-24 | — | — | US | disclosed |
| WO-2009101216-A2 | OMEGA-CYCLOHEXYLALKAN-1-OLES AND USE THEREOF AS ANTIMICROBIAL ACTIVES TO COMBAT BODY ODOR | SYMRISE GMBH & CO. KG (DE) | 2009-08-20 | — | — | WO | disclosed |
| US-20090123392-A1 | FRAGRANCE ACCORDS TO COMBAT THE PERCEPTION OF BODY ODOR | SYMRISE GMBH & CO. KG (DE) | 2009-05-14 | — | — | US | disclosed |
| EP-2014273-A1 | Use of methyl methyl ether and another ether to provide a feeling of cleanliness and purity | Symrise GmbH & Co. KG (DE) | 2009-01-14 | — | — | EP | disclosed |
| EP-1651037-A1 | SECONDARY ALCOHOLS USED AS ANTIMICROBIAL AGENTS | Symrise GmbH & Co. KG (DE) | 2006-05-03 | — | — | EP | disclosed |
| WO-2005004601-A1 | SECONDARY ALCOHOLS USED AS ANTIMICROBIAL AGENTS | SYMRISE GMBH & CO. KG (DE) | 2005-01-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12110472-B2 | Perfuming ingredients with lily of the valley note | PIR, ALG3, PNN | TYR 900/4885NPSR1 3227/4885PGK1 158/4885 |
| US-12031106-B2 | Use of 1-ethyl-4,4-dimethyl-cyclohexane derivatives as fragrances | ACMSD, ETV1, HTR1D | TYR 3675/4885NPSR1 2279/4885PGK1 537/4885 |
| US-20090238787-A1 | ODOUR-REDUCING SUBSTANCES | ADH1A, ADH1C, ALDH1A1 | TYR 677/4885NPSR1 392/4885PGK1 3422/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.